Clinical Study In Patients With Type 2 Diabetes Uncontrolled On OAD Treatment A total of 1170 patients with type 2 diabetes were randomized in an open-label, 30-week, active-controlled study (Study A: NCT05058147) to evaluate the efficacy and safety of SOLIQUA 100/33 compared to the individual components, insulin glargine 100 units/mL and lixisenatide
Table 4 Effects of ELA on microbial inactivation in fruits and vegetables
Logging your side effects allows you to capture common experiences in real time, including nausea, fatigue, appetite changes, and GI symptoms
Give each dose level at least four to eight weeks before concluding it is not working
Sintetizzata in particolare nel fegato e nei reni, lALCAR svolge un ruolo importante Scopri di pi Si tratta dello stesso principio attivo, ma il Nicetile un farmaco con indicazioni terapeutiche e dosaggi specifici